---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-26-000538"
form_type: "8-K"
ticker: "BBNX"
cik: "0001674632"
company_name: "Beta Bionics, Inc."
filed_at: "2026-01-30T23:59:59+00:00"
generated_at: "2026-05-16T05:59:03.212455+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Beta Bionics receives FDA Warning Letter after June 2025 inspection; cites quality system deficiencies

## Summary
- FDA Warning Letter follows June 2025 inspection of Irvine facility; cites non-conformities in Quality Management System, Medical Device Reporting, and Corrections/Removals.
- Warning Letter does not restrict production, marketing, manufacturing, or distribution, nor ability to seek FDA 510(k) clearance.
- Company preparing written response; corrective actions already underway; no assurance FDA will be satisfied with outcome.
- Company reiterates Mint commercialization guidance for end of 2027 is not materially impacted by Warning Letter.

## SEC filing metadata
- accession: 0001171843-26-000538
- form_type: 8-K
- ticker: BBNX
- cik: 0001674632
- company_name: Beta Bionics, Inc.
- filed_at: 2026-01-30T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1674632/000117184326000538/0001171843-26-000538-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1674632/000117184326000538/f8k_012926.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-26-000538
- JSON: https://secwatch.observer/filing/0001171843-26-000538.json
- Plain text: https://secwatch.observer/filing/0001171843-26-000538.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.